An enzyme-linked immunosorbent assay (ELISA) was used to determine the levels of brucella-specific IgG, IgM and IgA in 173 patients with acute brucellosis, 22 patients with chronic brucellosis and in 281 controls consisting of 98 patients with other infectious etiologies, 20 patients with non-infectious diseases and 163 normal healthy adults. The ELISA results were compared with culture findings, the results of slide agglutination tests with Brucella melitensis (M), B. abortus (A) and Ross Bengal (RB) antigens, and of tube and microagglutination tests. Brucella cultures were positive in 53 and 5 % of patients with acute and chronic brucellosis respectively. The slide agglutination tests with A, M, A plus M and RB antigens were positive in 42,44,51 and 98 % of patients with acute brucellosis and in 23, 27, 27 and 64 % of patients with chronic brucellosis. There was no significant difference in the results between the tube and microagglutination tests regardless of the type of antigen used. At a titre of ^ 80 or ^ 160 these tests were positive in 98 % and 92 % of patients with acute brucellosis and 60 and 40 % of patients with chronic brucellosis. The brucella culture and agglutination tests were negative for all the controls.
INTRODUCTION
Human brucellosis is still an important infectious disease problem in many parts of the world especially in the Mediterranean countries and the Middle East (FAO/WHO, 1971; Abdussalam & Fein, 1976; Kaufman & Mortone, 1980; Young, 1983; Manes, 1983) . The diagnosis depends on a high index of clinical suspicion, culture findings and the demonstration of elevated antibody titres. The varied and non-pathognomonic symptomatic presentation of the disease presents a great challenge to clinicians, especially in the chronic stage in which symptoms are usually vague, the course of illness atypical and the confirmatory diagnostic tests unreliable (Kerr et al. 1966; Payne, 1974) . Culture of brucella microorganisms from body specimens is time consuming and is often unsuccessful particularly in the chronic form (Wilson & Merrifield, 1951) . Thus the diagnosis of chronic brucellosis depends largely on serologic tests (Kerr et al. 1968; Alton, Jones & Pietz, 1975; White, 1978; Young, 1983) .
Agglutination tests have been the most commonly used. These tests, however, suffer from a high false negative result rate, take 1-2 days to perform, usually require rising titres for diagnosis and cannot per se differentiate the classes of antibodies involved (Kerr et al. 1968; Buchanan & Faber, 1980; Klein & Behan, 1981) . Tests such as the Coombs anti-human-globulin (Otero, Palenque & Noriega, 1982) complement fixation (Macdonald & Elmslie, 1967) indirect fluorescent antibody (IFA) (Biegeleisen, Bradshaw & Moody, 1962; Edwards, Tannahill & Bradstreet, 1970) and radioimmunoassay (RIA) (Parratt et al. 1977) have been used to differentiate immunoglobulin (Ig) classes in patients with brucellosis.
Recently a simple and rapid ELISA test for the determination of brucella-specific IgG, IgM and IgA in serum has shown promising results (Magee, 1980; Gilbert & Hawes, 1981; Sippel, El-Masry & Farid, 1982; De Klerk & Anderson, 1985) . We, in addition have reported a high sensitivity and specificity of ELISA when used on cerebrospinal fluid for the diagnosis of patients with neurobrucellosis (Strannegard, Araj & Fattah, 1985; Araj, et al. 1986) .
This study evaluates the use of ELISA for measuring brucella-specific IgG, IgM and IgA in serum, and defines the limits of titres in relation to culture, slide, tube and microagglutination tests for the diagnosis of patients with acute and chronic brucellosis.
MATERIALS AND METHODS

Study location and population
This study was carried out on patients from Jahra Hospital and Mubarak Al Kabeer Teaching Hospital in Kuwait, during the period from May 1985 through December 1985. A total of 551 serum specimens were obtained, 195 from brucella patients and 356 from control patients, during their first hospital visit and were stored at -2 0 °C until tested.
Based on objective and subjective assessment of disease history, clinical symptoms, epidemiologic evidence, serologic and culture results the patients and controls were grouped as follows:
Group 1. A total of 173 patients with acute brucellosis. All these patients had a history of drinking raw milk and or contact with goats, cows and camels. They had systemic manifestations compatible with this disease and the diagnosis was confirmed by serology in all and by positive culture results in 91 patients. The distribution of these patients according to age and sex is shown in Table 1 . Group 2. Twenty-two patients suspected of having chronic brucellosis. A history of raw milk ingestion, animal contact or previous infection with brucella over 1 year ago were reported by them. All of these patients had persisting symptoms similar to those described by Kerr et al. (1966) and McDevitt (1973) lasting over 1 year. The distribution of these patients according to age and sex is also shown in Table 1 .
Group 3. Ninety-eight patients with infectious diseases other than brucellosis. Infection in these patients was due to Salmonella sp. (23 patients), Escherichia coli Group 4. Twenty patients with non-infectious diseases. The diseases in these patients were diabetes (9 patients), rheumatoid arthritis (5), systemic lupus erythematosis (4) and leukaemia (2).
Group 5. A total of 162 presumably healthy individuals. These individuals had no history of brucellosis or any unusual febrile illness for the last 2 years. All had been living in Kuwait for a minimum of 4 years. They consisted of hospital (75) and non-hospital personnel (67) of whom 88 were males and 76 females. The mean age was 34 years (range 7-70).
Group 6. Seventy-six sera from British subjects. These specimens were kindly provided by the serology section, St Thomas's Hospital and Medical School, London. They were seronegative for brucella by the slide Rose Bengal and tube agglutination tests. They were used as negative controls to determine the optical density for the end-point titres in the ELISA tests. 
Brucella tube agglutination test (SAT)
The SAT was carried out on doubling dilution of serum from 1:40 to 1:1280 using the A and M antigens (Wellcome) according to the instruction of manufacturer.
Brucella microagglutination test (MAT)
The MAT was carried out as described by Bettelheim, Maskill & Pearce (1983) using B. abortus strain 1119-3 (courtesy of Dr Brown, National Veterinary Services Laboratories, Ames, Iowa, USA).
Culture of body specimens
The culture and identification of brucella and other microorganisms from body specimens were performed according to established procedures (Lennett et al. 1980) . The brucella agar medium was supplemented with human plasma negative for brucella antibodies. The brucella cultures were reported as negative after 6 weeks of incubation.
Brucella ELISA
The ELISA antibody titres of brucella-specific IgG, IgM, and IgA in serum specimens were determined as previously described (Araj et al. 1986) . Briefly, Nunc 96-well microtitration plates were coated with 50 /il of predetermined antigen from a heat-killed B. melitensis isolate. After washing, 50 fi\ serum samples were added to the wells and diluted two-fold from 1/100 to 1/12800. The plates were incubated at 37 °C for 2 h and washed again. Alkaline phosphatase conjugated anti-human IgG or IgM or IgA (Sigma Chemical Co., USA) was added to the wells. The plates were then incubated, washed and P-nitrophenyl phosphate (Sigma) added. The reaction was stopped after 45 min incubation at 37 °C by addition of 3 N sodium hydroxide and the plates were read at 405 nm in a Titertek Multiscan 8-channel spectrophotometer (Flow Laboratories, Scotland). The antibody titre in the test specimen was calculated using cut-off optical densities of two standard deviations above the mean optical density (O.D.) of 76 brucella negative control serum samples from British individuals. Background activity of conjugates and sera was tested for using antigen free-wells, and wells coated with bovine serum albumin (0-010 mg/ml) incubated with conjugate alone, with sera from patients or from controls plus conjugate. Day-to-day variation was determined by testing five positive (at 1/800 dilution) and five negative sera (at 1/100 dilution) daily for 2 months. In each instance the variation in O.D. was less than 10%. Finally, in each run serial dilutions of the same positive (titre 3200) and negative (titre 100) control sera were included in each plate. If the titres of the control sera varied by greater than one dilution step all sera on the plate were tested again. 
Evaluation of ELISA in human brucellosis
Statistical analysis
Differences in serological test results were assessed by means of the x 2 test. Significant differences were considered when the probability P was less than 005.
RESULTS
Patient population
The male to female ratio was 1:1-5 and 1:3 for the patients with acute and chronic brucellosis respectively. The mean age for the acute cases was 32 yrs (90% < 40 yrs) and for the chronic cases was 44 yrs (73% ^ 40 yrs) ( Brucella culture B. melitensis was recovered from 53% (91/173) and 5% (1/22) of patients with acute and chronic brucellosis respectively. The time of culture detection varied from 1-28 days (Mean 11 days) of incubation and the modal recovery was seen between the 8th and 10th day of incubation. Of the 92 positive cultures, 13% were recovered during the first week, 65% during the second, 19% during the third and 3 % during the fourth week (Table 2) .
Slide agglutination tests
Using the B. melitensis (M) antigen the slide agglutination was positive in 44 and 23% of patients with acute and chronic brucellosis respectively. Similar results (42 % for acute and 27 % for chronic patients) were obtained using the B. abortus (A) antigen. A combination of both tests was positive in 51 % of patients with acute and 27 % with chronic brucellosis. The Rose Bengal (RB) test, however, was positive in 97 and 04% of patients with acute and chronic brucellosis respectively (Table 3) .
All those specimens which were positive by cither M or A antigens were also positive by RB antigen. The slide agglutination tests with the three antigens were negative with all the 281 control specimens.
Tube agglutination test {SAT)
A SAT titre of ^ 80 for the A antigen was obtained in 98 % (169/173) and 59 % (13/22) of patients with acute and chronic brucellosis respectively (Table 4) . There was no significant difference in the results of SAT when patients with acute brucellosis who were culture positive (N = 91) were compared with those who were negative (iV = 82). At the same time 47 of the specimens (23 positive and 24 negative by culture) from patients with acute brucellosis were tested with the M antigen and showed similar positive results (94%) to those tested with A antigen. The SAT negative (titre < 80) specimens in the acute group showed higher titres when rctested after 2 weeks. However, there was no change in titre for the SAT negative specimens in the chronic group when similarly retested. 
Microagglulinalion test (MAT)
The MAT showed similar results to the SAT (Tables 3, 4 ). Slight differences, however, were observed when comparing the titres obtained in both tests. Eighty per cent of the specimens were within one dilution step difference, 16 % within two and 4% within three dilution steps (Table 5) .
Brucella ELISA
The distribution of brucella-specific IgG, IgM and IgA for the different group of patients and controls are presented in Fig. 1 . The reciprocal titres for brucella-specific IgG in the acute and chronic cases were ^ 1600 in 97*7 and 100 % of specimens respectively. On the other hand only 2 % of the healthy controls and patients with diseases other than brucella showed such a titre.
Brucella-specific IgM titres of ^ 400 were detected in 99 and 35 % of patients with acute and chronic brucellosis respectively and in 2 % of control groups. 
Evaluation of ELISA in hitman brucellosis
465 Brucella-specific IgA titrcs of ^ 200 were detected in 98 and 100% of patients with acute and chronic brucellosis and in < 1 % of control groups.
Sensitivity and specificity of tests
The sensitivity and specificity of various tests in relation to diagnosis of patients with acute (N = 173) and chronic {N = 22) brucellosis as compared to control groups (iV = 280) are presented in Table 6 .
DISCUSSION
The strict enforcement of the eradication programme among livestock has proven successful for the developed countries in minimizing the incidence of brucellosis (Alausa, 1980; Wise, 1980) . The state of Kuwait (population 1-5-1-7 million) is one of the developing countries where the incidence of brucellosis is still on the increase. A total of 732 cases were reported in 1984 with an incidence of 42-78/100000 population as compared to 12 cases in 1976 with an incidence of 1-15/100000 (Health Statistic Annual Report, 1984) . In 1985, 1168 cases were reported with an incidence of 68-9/100000 population (personal communication). Investigation of these cases indicated that the infections occurred mainly in rural areas among Bedouins where the traditional drinking of raw milk (goats, camels or cows), the tending of domestic animals or the sharing of accommodation with them provided the main sources of infection -a finding similar to those reported from neighbouring countries (Makarem, Karjoo & Omidi, 1982; Kambal el al. 1983) . This very substantial increase in reported cases could be partly due to the increased awareness of the disease among clinicians and the availability of improved diagnostic facilities.
Most of the conventional diagnostic tests have proved unreliable for the diagnosis of brucellosis, especially the chronic stage (Kerr el al. 1966 (Kerr el al. , 1968 FAO/WHO, 1971; Payne, 1974) . In this study, culture yielded positive results in 53 and 5 % only of patients with acute and chronic brucellosis. The sensitivity of the slide agglutination tests with M and A antigens was very low for both the acute (40-50%) and the chronic (27 %) stages of the disease while the sensitivity of the RB antigen test was 97 and 64%. On the other hand, the sensitivity of SAT was high (98% and 92%) where the titres were > 80 and > 160 in patients with acute disease and was lower (59 and 45%) in patients with chronic brucellosis. These results are consistent with those previously reported (Kerr el al. 1966; Payne, 1974; Diaz et al. 1978; Kambal et al. 1983) . The SAT and MAT results were comparable with minor differences only and were similar to the findings of Bettelheim, Maskill & Pearce (1983) .
The value of agglutination tests are severely limited by the unacceptably high proportion of false negative results which could be due to a number of factors such as the type of antigen and test used, a prozone phenomenon, class(es) of antibody involved, stage of the disease or to any combination of these (Coghlan & Longmore, 1973; Payne, 1974; Diaz, Maravi-Poma & Rivero, 1976; McNaught et al. 1977; Kambal et al. 1983) . The cut-off SAT titres for positive or negative results may also vary depending on the specimen tested, antigen used and the geographic location of endemic or non-endemic areas (Diaz, Maravi-Poma & Rivero, Sahs, 1978) . Our analyses of SAT results have been based on the most commonly considered positive titres, > 80 and ^ 160. The specificity was 100% for both titres but the sensitivity decreased in both acute and chronic brucellosis when based upon higher titres. Demonstration of rising titres from two specimens is of greater diagnostic significance than a single titre. In endemic areas, however, a rising titre may not bo observed and thus knowledge of the Ig classes, which ELISA provides, would be of great importance.
Attempts to determine Ig classes to brucella in order to identify the stage of the disease (Reddin et al. 1965; Wilkinson, 1966; Kerr et al. 1966 Kerr et al. , 1968 Coghlan & Weir, 1967) , have been made using methods such as direct agglutination in the presence or absence of 2-mercapto-ethanol, Coombs tests and complement fixation tests. None of these, however, is sufficiently specific (Wilkinson, 1966; Kerr et al. 1968; Diaz Maravi-Poma & Rivero, 1976; White, 1978) . Direct determination of brucella-specific IgM, IgG and IgA was made possible by the use of primary assays such as IFA (Edwards, Tannahill & Bradstreet, 1970) , RIA (Parratt et al. 1977) and more recently by ELISA (Magee 1980; Gilbert & Hawes, 1981; De Klerk & Anderson 1985; Strannegard, Araj & Fattah, 1985; Araj et al. 1986) . These tests avoid the complications of non-agglutinable antibodies. ELISA also avoids the subjectivity in interpreting results of IFA tests and the radioactive hazards of RIA. The antibody conjugates in ELISA have longer shelf lives than IFA or RIA reagents and the test is suitable for screening large number of samples and for automation. Our ELISA results are in agreement with the established findings that in acute (recurrent or current) cases of brucellosis IgM is present in the serum alone or together with IgG and IgA, while in the chronic cases the amount of IgM is minimal or is absent with elevated IgG alone or together with IgA (Coghlan & Longmore 1973; White, 1978; Gilbert & Hawes, 1980; Magee, 1980; Sippel, El-Masry & Farid, 1982) . In addition ELISA showed good correlation with the RB and SAT for the diagnosis of acute cases and was superior for the diagnosis of chronic cases of brucellosis.
The limits of normal levels of each Ig class, in ELISA, has to be established for the community tested in each geographic location. This is of special importance for determining the sensitivity and specificity of the ELISA test. Being aware of the endemicity of brucellosis in our community, the sera from British population (where the incidence of brucellosis is negligible) was used to standardize the assay. This was needed in order to establish the actual background antibody levels in our population to avoid false positive results and over diagnosis especially when using ELISA which demonstrated higher sensitivity than conventional tests, a feature noted both in this study and others (De Klerk & Anderson, 1985) . The specificity of brucella ELISA varied with the titre. A very high level of specificity for brucellosis was achieved in relation to other infections at titres of ^ 1600, ^ 400 and ^ 200 for IgG, IgM and IgA respectively. The test has also proved to be highly sensitive and specific in the diagnosis of neurobrucellosis using cerebrospinal fluid specimens (Araj et al. 1986) . One of the controls who had a brucella IgG titre of 1600 suffered from S. typhi infection. When tested again after 2 weeks the same brucella titre was obtained indicating no anamnestic reaction. Results from the control groups showed the presence of all Ig classes and there was no significant difference among the three groups for each class of Ig. The normal controls consisted of individuals representing different professions and the presence of at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0022172400063634 Downloaded from https://www.cambridge.org/core. IP address: 54.70.40.11, on 23 Mar 2019 at 11:13:14, subject to the Cambridge Core terms of use, available antibody, especially the IgG, in the group reflects the extent of a wide range of exposure to brucella in the community. Among the 4 healthy controls whose sera showed IgG titres of 1600, 2 were from personnel working in a microbiology laboratory and the other 2 were from non-hospital clerks. It is well documented that many persons who are occupationally-exposed to brucellosis have high serological titres but are asymptomatic (McDevitt, 1970 (McDevitt, , 1973 . In a brucella endemic area, such as Kuwait, the difference in Ig levels between the 'high risk individuals' and the rest of the community may not be that distinct. However, the ELISA IgG levels in patients with acute or chronic brucellosis were significantly different from the normal controls. Similar results were also observed in relation to the IgA. The IgM levels, however, showed significant differences between acute and chronic or control groups while it was not significantly different between the chronic and controls. The presence of small amounts of IgM, especially in the control groups, could reflect either overt or subclinical past infection that is no longer active (Coghlan & Weir, 1967; Coghlan & Longmore, 1973) . Moreover the fact that IgM levels were low in some patients suspected of having brucellosis, was thought to be due to their having received antibiotics before hospital admission (Magee, 1980; Sippel, El-Masry & Farid, 1982) . Our patients with acute brucellosis had all classes of Ig at the time of their hospital visit. This is in agreement with the findings reported by Sippel, El-Marsy & Farid (1982) , from Egypt, but differ from those reported by Reddin et al. (1965) and Parratt et al. (1977) from England who found that some patients had elevated levels of brucella IgM antibody only. This inconsistency was considered to reflect differences between developed and developing countries in methods used for diagnosis, the habits of the population, and the time taken to make the diagnosis (Sippel, El-Marsy & Farid, 1982) . In this study and as noted before (Magee, 1980) none of the sera gave positive results from established methods and negative results from ELISA confirming that ELISA would be an adequate substitute for conventional tests.
In conclusion brucella ELISA is a rapid, sensitive and specific assay with a superior performance over conventional tests. It provides a profile of brucellaspecific IgM, IgG and IgA for the diagnosis of patients with acute or chronic brucellosis and is suited for mass screening.
